Total: 2198

    The management of myelofibrosis: a British Society for Haematology guideline

    Br. j. haematol; 204 (1), 2024
    This document represents an update of the British Society for Haematology guideline on Myelofibrosis first published in 2012 and updated in 2015 These guidelines aim to pro-vide healthcare professionals with clear guidance on stratified management for primary myelofibrosis (PMF)...

    Guideline for the diagnosis and management of marginal zone lymphomas: a British Society of Haematology guideline

    Br. j. haematol; 204 (1), 2024
    The objective of this guideline is to provide healthcare professionals with clear guidance on the diagnosis and management of patients with marginal zone lymphoma (MZL)....

    Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology guideline

    Br. j. haematol; 204 (1), 2024
    This document represents an update of the British Society for Haematology (BSH) guideline on myelofibrosis (MF) first published in 2012 and updated in 2015.1 This guideline aims to provide healthcare professionals with clear guidance on the diagnosis and prognostic evaluation of primary m...

    Guideline No. 445: management of chronic pelvic pain

    J. obstet. gynaecol. Can; 46 (1), 2024
    To provide evidence-based recommendations for the management of chronic pelvic pain in females. This guideline is specific to pelvic pain in adolescent and adult females and excluded literature that looked at pelvic pain in males. It also did not address genital pain. The intent is to benefit patients wi...

    European Society of Clinical Microbiology and Infectious Diseases guidelines on diagnosis and treatment of brain abscess in children and adults

    Clin. microbiol. infect; 30 (1), 2024
    These European Society of Clinical Microbiology and Infectious Diseases guidelines are intended for clinicians involved in diagnosis and treatment of brain abscess in children and adults. Methods: Key questions were developed, and a systematic review was carried out of all studies published since 1 Janua...

    Consolidated guidelines on differentiated HIV testing services

    hese guidelines outline a public health approach to strengthening and expanding HIV testing services (HTS). They present and discuss key updates to WHO guidelines on HTS, with a focus on new evidence, new recommendations, good practices and operational considerations that respond to the changing needs of...

    Updated recommendations for the treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum (‎syphilis)‎ and new recommendations on syphilis testing and partner services

    These guidelines are intended for policy-makers, programme managers, health workers and any other public health professionals responsible for planning or implementing STI services (stand-alone or integrated with other health services). These guidelines will also be a resource for donor and development ag...

    Recommendations for the treatment of Trichomonas vaginalis, Mycoplasma genitalium, Candida albicans, bacterial vaginosis and human papillomavirus (‎anogenital warts)‎

    These guidelines focus on the treatment for infections caused by Trichomonas vaginalis, Mycoplasma genitalium and Candida albicans, and treatment for the conditions of bacterial vaginosis and anogenital warts. Trichomoniasis, caused by the protozoan Trichomonas vaginalis, is the most common non-viral STI...

    Fiscal policies to promote healthy diets: WHO guideline

    In current food environments, energy-dense, nutrient-poor foods are readily available, heavily marketed and relatively cheap. Consumers are challenged to make healthy and affordable food-related decisions that are consistent with a healthy diet. Affordability of food is a key determinant of the food envi...

    Guidelines for the prevention of bloodstream infections and other infections associated with the use of intravascular catheters: part I: peripheral catheters

    In the context of the prevention of infections associated with IV catheters, these guidelines (Part 1) provide guidance on best practices for the prevention of BSIs and other infections associated with peripherally-inserted IV catheters, while a subsequent WHO guideline (Part 2) to be developed in 2024 w...